Silphium Asset Management’s Labcorp LH Stock Holding History

Silphium Asset Management’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-2,328	Closed	-$319K	–	91
2017 Q4	$319K	Buy	+2,328	New	+$308K	0.39%	37

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

GCM

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Silphium Asset Management's LH Position: Q1 2018 in Review

Silphium Asset Management sold out of Labcorp (LH) in Q1 2018, closing a stake of 2,328 shares — an estimated $319K sold.

Silphium Asset Management first reported a position in LH in Q4 2017 and held it in 1 quarter. The position peaked at $319K in Q4 2017. 792 funds tracked by Wall St. Rank hold LH as of Q1 2018.

Silphium Asset Management reported no remaining Labcorp position as of Q1 2018 after selling out during the quarter.
Silphium Asset Management sold 2,328 Labcorp shares in Q1 2018, an estimated $319K.
Silphium Asset Management first reported a position in Labcorp in Q4 2017 and held it in 1 quarter.
Silphium Asset Management's Labcorp position peaked at $319K in Q4 2017.
792 funds tracked by Wall St. Rank held Labcorp as of Q1 2018.

Based on Silphium Asset Management's 13F filing for Q1 2018, filed 30 Jan 2025.